PCA
NVO

Private Capital Advisors’s Novo Nordisk NVO Stock Holding History

Private Capital Advisors’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,810
Closed -$216K – 80
2024
Q3 		$216K Buy
+1,810
New +$241K 0.02% 71
2023
Q3 		– Sell
-6,000
Closed -$485K – 95
2023
Q2 		$485K Buy
+6,000
New +$490K 0.08% 55

Other funds holding NVO

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Koshinski Asset Management
Koshinski Asset Management Decatur, Illinois $1.6B AUM 20.7% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Private Capital Advisors's NVO Position: Q4 2024 in Review

Private Capital Advisors sold out of Novo Nordisk (NVO) in Q4 2024, closing a stake of 1,810 shares — an estimated $216K sold.

Private Capital Advisors first reported a position in NVO in Q2 2023 and held it in 2 quarters. The position peaked at $485K in Q2 2023. 1,663 funds tracked by Wall St. Rank hold NVO as of Q4 2024.

  • Private Capital Advisors reported no remaining Novo Nordisk position as of Q4 2024 after selling out during the quarter.
  • Private Capital Advisors sold 1,810 Novo Nordisk shares in Q4 2024, an estimated $216K.
  • Private Capital Advisors first reported a position in Novo Nordisk in Q2 2023 and held it in 2 quarters.
  • Private Capital Advisors's Novo Nordisk position peaked at $485K in Q2 2023.
  • 1,663 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2024.

Based on Private Capital Advisors's 13F filing for Q4 2024, filed 21 Jan 2025.